Webcast

Cann Group Investor Briefing – 16 December

December 16, 2020

Cann Group Investor Briefing – 16 December

Cann Group Limited (ASX: CAN) Webcast Replay

Cann Group (ASX: CAN) is building a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and approved overseas export markets.

As a part of our ‘The Insiders’ series, CEO Peter Crock provides valuable insights to the company, its key markets and industry, and future prospects.

Recorded on 16 December 2020 at 12pm (AEDT).

Join the next The Insider webcast

Speak to our Advisor team about this company

FEATURE SPEAKERS

Peter Crock

Chief Executive Officer - Cann Group Limited (ASX: CAN)

Cann Group (ASX: CAN) is building a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and approved overseas export markets. The company has established facilities in Melbourne, and Cann’s expertise and partnerships support the rapid growth of globally competitive Australian research and production capabilities. Cann intends to be a leading developer and supplier of cannabis, cannabis resin and medicinal cannabis products. These extracts will be provided to researchers and prescribing clinicians to investigate, understand and optimise the therapeutic effectiveness of medicinal cannabis for specific medical conditions.

Speak to our Advisor team about this company



By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.